ClariTrial | Search Clinical Trials

Explore/C4 Therapeutics

Status

Phase

734 results for “C4 Therapeutics”

Page 1 of 49

Recruiting

Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT)

N/AStrokeHemiparesis of the Upper Limb Following StrokeStroke Rehabilitatiom

Anodal tDCS combined with mCIMTCathodal tDCS combined with mCIMTBihemispheric tDCS combined with mCIMT+1 more

King Saud University300 participants1 site · Saudi ArabiaCompletes Apr 2025

Compare CT.gov Full analysis →

Completed

Results posted

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Phase 2Systemic Lupus Erythematosus

BMS-986165Placebo

Bristol-Myers Squibb363 participants192 sites · United States, Argentina, AustraliaCompletes Jun 2021

Compare CT.gov Full analysis →

Recruiting

Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

Phase 2Lymphoma, Mantle-Cell

ObinutuzumabGlofitamabVenetoclax Oral Product+1 more

The Lymphoma Academic Research Organisation100 participants16 sites · Belgium, FranceCompletes May 2028

Compare CT.gov Full analysis →

Completed

N/ARheumatoid Arthritis

UCB Pharma SA81 participants15 sites · SpainCompletes Mar 2014

Compare CT.gov Full analysis →

UNKNOWN

Coblation in Endoscopic Sinus Surgery

N/ABlood Loss

Coblation polypectomy

Western University, Canada22 participants1 site · CanadaCompletes May 2014

Compare CT.gov Full analysis →

Completed

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

Phase 2Covid19

TrimodulinPlacebo (human albumin 1%)

Biotest166 participants17 sites · Brazil, France, RussiaCompletes Jun 2021

Compare CT.gov Full analysis →

UNKNOWN

Study of Efficacy of Different Treatment Regimens of Olokizumab

Phase 3COVID-19

OlokizumabStandard therapy

R-Pharm198 participants5 sites · RussiaCompletes Oct 2022

Compare CT.gov Full analysis →

UNKNOWN

Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients

N/ALupus Erythematosus, Systemic

Contemplative-Based Intervention for People Living with SLEHealth Enhancement Program (HEP)

University of Toronto50 participantsCompletes Jul 2021

Compare CT.gov Full analysis →

Terminated

Results posted

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

Phase 2Cholangitis, Sclerosing

All-trans retinoic acid

Yale University2 participants1 site · United StatesCompletes Dec 2020

Compare CT.gov Full analysis →

Completed

Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

Early Phase 1Polycystic Ovary Syndrome

Cyproterone compound + SpironolactoneMetforminPioglitazone

Shiraz University of Medical Sciences90 participants1 site · IranCompletes Nov 2018

Compare CT.gov Full analysis →

Completed

Results posted

ClosureFAST - Radiofrequency Great Saphenous Vein Treatment

N/AVenous Reflux

RF ablation (ClosureFAST)

Medtronic Endovascular326 participantsCompletes May 2012

Compare CT.gov Full analysis →

UNKNOWN

Study of Neurobiological Predictors of Response to Non-invasive Neurostimulation and Genetic Susceptibility to Dementia in Patients With Amnestic Mild Cognitive Impairment

N/AMild Cognitive Impairment

Transcranial Direct Current Stimulation (tDCS)

Suellen Marinho Andrade50 participants1 site · BrazilCompletes Dec 2022

Compare CT.gov Full analysis →

Terminated

A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus

Phase 1Systemic Lupus Erythematosus

GLPG3970 film-coated tabletPlacebo film-coated tablet

Lakefront Biotherapeutics NV11 participants14 sites · Bulgaria, Moldova, PolandCompletes Oct 2021

Compare CT.gov Full analysis →

UNKNOWN

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

N/AKidney TransplantationAntibody Mediated Rejection

Sessions of conventional apheresisSessions of news apheresis with double filtration

University Hospital, Grenoble16 participants1 site · FranceCompletes Mar 2020

Compare CT.gov Full analysis →

Completed

Results posted

Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal

Phase 2Parkinson's Disease

PlaceboL-dopa 35 mgL-dopa 70mg+2 more

Impel Pharmaceuticals32 participants5 sites · AustraliaCompletes Jun 2019

Compare CT.gov Full analysis →

1–15 of 734

Explore/C4 Therapeutics

Status

Phase

734 results for “C4 Therapeutics”

Page 1 of 49

Recruiting

Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT)

N/AStrokeHemiparesis of the Upper Limb Following StrokeStroke Rehabilitatiom

Anodal tDCS combined with mCIMTCathodal tDCS combined with mCIMTBihemispheric tDCS combined with mCIMT+1 more

King Saud University300 participants1 site · Saudi ArabiaCompletes Apr 2025

Compare CT.gov Full analysis →

Completed

Results posted

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

Phase 2Systemic Lupus Erythematosus

BMS-986165Placebo

Bristol-Myers Squibb363 participants192 sites · United States, Argentina, AustraliaCompletes Jun 2021

Compare CT.gov Full analysis →

Recruiting

Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

Phase 2Lymphoma, Mantle-Cell

ObinutuzumabGlofitamabVenetoclax Oral Product+1 more

The Lymphoma Academic Research Organisation100 participants16 sites · Belgium, FranceCompletes May 2028

Compare CT.gov Full analysis →

Completed

N/ARheumatoid Arthritis

UCB Pharma SA81 participants15 sites · SpainCompletes Mar 2014

Compare CT.gov Full analysis →

UNKNOWN

Coblation in Endoscopic Sinus Surgery

N/ABlood Loss

Coblation polypectomy

Western University, Canada22 participants1 site · CanadaCompletes May 2014

Compare CT.gov Full analysis →

Completed

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

Phase 2Covid19

TrimodulinPlacebo (human albumin 1%)

Biotest166 participants17 sites · Brazil, France, RussiaCompletes Jun 2021

Compare CT.gov Full analysis →

UNKNOWN

Study of Efficacy of Different Treatment Regimens of Olokizumab

Phase 3COVID-19

OlokizumabStandard therapy

R-Pharm198 participants5 sites · RussiaCompletes Oct 2022

Compare CT.gov Full analysis →

UNKNOWN

Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients

N/ALupus Erythematosus, Systemic

Contemplative-Based Intervention for People Living with SLEHealth Enhancement Program (HEP)

University of Toronto50 participantsCompletes Jul 2021

Compare CT.gov Full analysis →

Terminated

Results posted

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

Phase 2Cholangitis, Sclerosing

All-trans retinoic acid

Yale University2 participants1 site · United StatesCompletes Dec 2020

Compare CT.gov Full analysis →

Completed

Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

Early Phase 1Polycystic Ovary Syndrome

Cyproterone compound + SpironolactoneMetforminPioglitazone

Shiraz University of Medical Sciences90 participants1 site · IranCompletes Nov 2018

Compare CT.gov Full analysis →

Completed

Results posted

ClosureFAST - Radiofrequency Great Saphenous Vein Treatment

N/AVenous Reflux

RF ablation (ClosureFAST)

Medtronic Endovascular326 participantsCompletes May 2012

Compare CT.gov Full analysis →

UNKNOWN

Study of Neurobiological Predictors of Response to Non-invasive Neurostimulation and Genetic Susceptibility to Dementia in Patients With Amnestic Mild Cognitive Impairment

N/AMild Cognitive Impairment

Transcranial Direct Current Stimulation (tDCS)

Suellen Marinho Andrade50 participants1 site · BrazilCompletes Dec 2022

Compare CT.gov Full analysis →

Terminated

A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus

Phase 1Systemic Lupus Erythematosus

GLPG3970 film-coated tabletPlacebo film-coated tablet

Lakefront Biotherapeutics NV11 participants14 sites · Bulgaria, Moldova, PolandCompletes Oct 2021

Compare CT.gov Full analysis →

UNKNOWN

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

N/AKidney TransplantationAntibody Mediated Rejection

Sessions of conventional apheresisSessions of news apheresis with double filtration

University Hospital, Grenoble16 participants1 site · FranceCompletes Mar 2020

Compare CT.gov Full analysis →

Completed

Results posted

Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal

Phase 2Parkinson's Disease

PlaceboL-dopa 35 mgL-dopa 70mg+2 more

Impel Pharmaceuticals32 participants5 sites · AustraliaCompletes Jun 2019

Compare CT.gov Full analysis →

1–15 of 734